No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹8.73Prev. Close
₹8.61Turnover(Lac.)
₹0.2Day's High
₹8.73Day's Low
₹8.2752 Week's High
₹10.3252 Week's Low
₹5Book Value
₹0.83Face Value
₹2Mkt Cap (₹ Cr.)
8.69P/E
61.5EPS
0.14Divi. Yield
031 Jul 2025
12:00 AM
AGM
Announcement Date: 31 Jul, 2025
30 Aug 2025
12:00 AM
BookCloser
19 Jan 2026
12:00 AM
Board Meeting
Agenda : Audited Result
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 2.05 | 2.05 | 2.05 | 10.25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -1.15 | -1.25 | -1.3 | -9.46 |
Net Worth | 0.9 | 0.8 | 0.75 | 0.78 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1.03 | 1.94 | 1.03 | 1.01 |
yoy growth (%) | -46.89 | 88.46 | 1.84 | -19.64 |
Raw materials | -0.68 | -1.3 | -0.56 | -0.72 |
As % of sales | 65.93 | 66.92 | 55.04 | 71.82 |
Employee costs | -0.24 | -0.25 | -0.22 | -0.26 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.95 | 0.11 | -2.27 | -0.48 |
Depreciation | 0 | -0.01 | 0 | -0.01 |
Tax paid | 0.01 | -0.03 | 0 | 0 |
Working capital | -0.87 | 1.25 | 0.09 | -0.13 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -46.89 | 88.46 | 1.84 | -19.64 |
Op profit growth | -791.35 | -105.78 | 404.59 | 278.8 |
EBIT growth | -860.9 | -105.49 | 376.04 | 255.53 |
Net profit growth | -1,262.13 | -103.55 | 362.89 | -76.45 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,840.55 | 147.13 | 4,41,609.6 | 608.7 | 0.87 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,753.3 | 67.34 | 1,79,278.9 | 756 | 0.44 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,451.2 | 67.12 | 1,50,648.83 | 467 | 0 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,417.05 | 30.93 | 1,14,469.38 | 384.64 | 0.92 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,329.35 | 34.46 | 1,10,955.12 | -219.4 | 0.6 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
J.V.R. Mohan Raju
Non-Exec & Non-Independent Dir
J Uma
Non Independent Non Executive Director / CFO
JAISON GEORGE
Independent Non Exe. Director
Reji Abraham
Independent Non Exe. Director
Bodeddula Nagi Reddy
Independent Non Exe. Director
Gorrela Pratheek Reddy
Company Sec. & Compli. Officer
Shailendra Vyas
H No 8-2-269/S PlotNo 31 RdNo2,
Sagar Co-Op Hous Banjara Hills,
Telangana - 500034
Tel: 91-40-23555161/23555181
Website: http://www.hindustanbiosciences.in
Email: mohan.hindustanbio@gmail.com, pharma.hindustanbio@
AURUM No. 4-50/P-II,
Plot No.57 Jayabheri, Seri Lingampally,
Hyderabad - 500032
Tel: 040 - 23818475 / 238
Website: www.vccipl.com
Email: info @vccipl.com /investor.relations@vccipl.com
Summary
Hindustan Bio Science Limited was initially incorporated as Garuda Cements Limited in December 1991. Earlier, it was engaged in cement manufacturing and due to sluggish in the industry, the Company di...
Read More
Reports by Hindustan Bio Sciences Ltd
What is the Hindustan Bio Sciences Ltd share price today?
What is the Market Cap of Hindustan Bio Sciences Ltd?
What is the PE and PB ratio of Hindustan Bio Sciences Ltd?
What is the 52 Week High and Low of Hindustan Bio Sciences Ltd?
What is the CAGR of Hindustan Bio Sciences Ltd?
What is the shareholding pattern of Hindustan Bio Sciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
